Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine

Esophageal cancers are highly aggressive tumors with poor prognosis despite some recent advances in surgical and radiochemotherapy treatment options. This study addressed the feasibility of drugs targeting epigenetic modifiers in esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinom...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Epigenetics
Main Authors: Ahrens, Theresa D, Timme, Sylvia, Hoeppner, Jens, Ostendorp, Jenny, Hembach, Sina, Follo, Marie, Hopt, Ulrich T, Werner, Martin, Busch, Hauke, Boerries, Melanie, Lassmann, Silke
Formato: Artigo
Idioma:Inglês
Publicado: Taylor & Francis 2015
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4623041/
https://ncbi.nlm.nih.gov/pubmed/25923331
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15592294.2015.1039216
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares